Results 201 to 210 of about 47,203 (289)

Therapeutic Use of Medical Cannabis Beyond Pain Management in Physical Medicine and Rehabilitation. [PDF]

Arch Intern Med Res
Cameron A, Fraix MP, Agrawal DK.
europepmc   +1 more source

UK Medical Cannabis Registry: A Two‐Year Prospective Observational Cohort Study of Clinical Outcomes in Insomnia

Neuropsychopharmacology Reports, Volume 46, Issue 4, December 2026.
Insomnia affects around one in ten adults. In this 2‐year UK Medical Cannabis Registry cohort study of 211 adults with insomnia, treatment with cannabis‐based medicinal products was associated with a sustained improvement in self‐reported sleep quality across 24 months.
Aran Koye, Simon Erridge, Evonne Clarke, Katy McLachlan, Ross Coomber, James J. Rucker, Mark W. Weatherall, Mikael H. Sodergren   +7 more
wiley   +1 more source

Cannabis and Wound Healing: A Narrative Review of Current Evidence and Applications to Facial Plastic Surgery. [PDF]

J Pers Med
Naimi BR, Hom DB.
europepmc   +1 more source

Hemp seed counting and morphometric analysis method comparison

The Plant Phenome Journal, Volume 9, Issue 1, December 2026.
Abstract The USDA ARS Hemp Germplasm Laboratory recently acquired over 800 hemp accessions (Cannabis sativa L.). Variation in hemp seed size characteristics is needed to develop quantitative standards to support the transition of hemp grain into a commodity.
Tyler Gordon, Zachary Stansell
wiley   +1 more source

Industrial Hemp and Tobacco as Multipurpose Crops: Traditional Uses, Contemporary Applications, and Future Perspectives. [PDF]

Plants (Basel)
Varga I, Andraković M, Crljić P, Đaković M, Antunović M, Tkalec Kojić M, Agić D.   +6 more
europepmc   +1 more source

The Kush Drug Epidemic in Sierra Leone: Public Health Implications, Socioeconomic Drivers and Health System Responses

Public Health Challenges, Volume 5, Issue 4, December 2026.
ABSTRACT Background Kush, a synthetic drug combining cannabinoids and nitazene opioids, has emerged as a major public health concern in Sierra Leone, with reported prevalence and clinical severity increasing markedly as it was first identified.
Alvin Turay, Ahmed Vandy, Uthman Okikiola Adebayo, Marie Ibranatu Kolipha‐Kamara, Augustus Osborne, Michael Lahai   +5 more
wiley   +1 more source

Evaluating the impact of cannabinoid extracts on chronic pain and quality of life in endometriosis patients - a pilot study. [PDF]

PLoS One
Kratz JW, Velho RV, Bock S, Sehouli J, Mechsner S.   +4 more
europepmc   +1 more source

Signal detection and characterisation of a novel drug–drug interaction between methadone and a synthetic cannabinoid receptor agonist

British Journal of Pharmacology, Volume 183, Issue 23, Page 6787-6800, December 2026.
Background and Purpose Little is known about how synthetic cannabinoid receptor agonist (SCRA) co‐use with other psychoactive substances may exacerbate risk of death. This study aimed to characterise the polypharmacy of deaths where SCRAs were detected at post‐mortem, investigate the cardiotoxicity of SCRAs and probe their inhibition of human ether‐a ...
Kirsten L. Rock, Louise M. Hesketh, Hongwei Cheng, Shuoqi Chen, Simon Hudson, Graeme Henderson, Jules C. Hancox, Michael J. Shattock, Michael J. Curtis, Caroline S. Copeland   +9 more
wiley   +1 more source

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross‐Sectional Survey Data

Arthritis Care &Research, Volume 78, Issue 11, Page 1791-1800, November 2026.
Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among patients with rheumatologic conditions and their associations with patient factors, patient‐reported perceived side effects, and positive impacts.
Susan Zhang, Samuel A.J. Lowe, Frank Sun, Allyson Jones, Tarek Turk, Joanne Olson, Pauline Paul, Shelby Yamamoto, Linda Kolewaski, Elaine Yacyshyn, Cheryl A. Sadowski   +10 more
wiley   +1 more source

Cannabinoid modulation of central amygdala population dynamics during threat investigation. [PDF]

Nat Commun
Yasmin F, Naskar S, Zaidi D, Kandil I, Kwon M, Rosas-Vidal LE, Patel S.   +6 more
europepmc   +1 more source